Cutting-edge immunotherapy treatment approved for another deadly cancer – Washington Post
Washington Post |
Cutting-edge immunotherapy treatment approved for another deadly cancer
Washington Post The FDA approval is the latest step forward for the fast-moving field of immunotherapy, which aims to bolster the immune system to attack malignancies. CAR T-cell therapies are among several approaches, along with treatments called checkpoint … Gilead cancer immunotherapy wins US approval with $373000 price Gilead Sciences (GILD) Announces Kite's Yescarta Becomes First CAR T Therapy Approved by FDA for Treatment of … |
